Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ashraf M Elhefni"'
Publikováno v:
Journal of Hematology. 4:131-136
Background: Non-Hodgkin lymphomas (NHLs) are heterogeneous group of lymphoproliferative malignancies with different patterns of behavior and response to treatment that usually originate in lymphoid tissues and can spread to other organs. The aim of t
Publikováno v:
OncoTargets and therapy
Ebtesam I Ahmad, Heba H Gawish, Nashwa MA Al Azizi, Ashraf M ElhefniClinical Pathology Department, Hematology and Oncology Unit of Internal Medicine Department, Faculty of Medicine, Zagazig University, Sharkia, EgyptBackground: Activating point mutat
Publikováno v:
Leukemia & Lymphoma. 53:2310-2311
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm that originates in an abnormal pluripotent stem cell. Imatinib mesylate (Gleevec, Glivec, formerly STI571) has revolutionized the man...
Publikováno v:
The Egyptian Journal of Haematology. 39:246
Introduction B-cell chronic lymphocytic leukemia (B-CLL) is characterized by accumulation of quiescent monoclonal CD5+ B cells, which arise from undefined defects in apoptotic cell death. murine double minute-2 (MDM2) oncoprotein exists in an autoreg
Publikováno v:
The Egyptian Journal of Haematology. 39:122
Background Immunoglobulin like transcript (ILT3) is an immunohibitory transmembrane receptor expressed by plasmacytoid dendritic cells (PDCs), monocytoid dendritic cells (MDCs), and monocytes/macrophages. ILT3 has been previously utilized as a highly